Baker, a patient and patient advocate based in the United Kingdom, received a diagnosis of essential thrombocythemia (ET) in ...

The lidERA Breast Cancer study is a phase 3, randomized, open-label trial testing whether the adjuvant therapy giredestrant ...

Compassionate nursing care significantly impacts the emotional well-being of patients and their families during cancer treatment. Nurses' ability to engage in normal conversations provides a sense of ...

Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered ...

Nona Baker received a diagnosis of essential thrombocythemia in 1991, followed by polycythemia vera in 2004. It’s been nearly ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...

Gratitude and resilience are central themes, emphasizing the importance of appreciating life's basics and community support ...

GISTs are solid tumors, primarily in the stomach, characterized by KIT and EGFR mutations, with Gleevec as a key treatment.

The FDA accepted a new drug application for zidesamtinib for previously treated locally advanced or metastatic ROS1-positive ...

At the 2025 International Kidney Cancer Symposium, Dr. Michael Staehler, of the University of Munich, highlighted the ...

Embracing uncertainty and finding strength in adversity are crucial for personal growth and resilience during a cancer ...

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...